Deleterious role of IFNgamma in a toxic model of central nervous system demyelination
Related Experiment Video
Updated: Aug 5, 2026

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Paula Maña1, David Liñares, Sue Fordham
1Neurosciences Research Unit, The Canberra Hospital, Australian National University Medical School, The Canberra Hospital, PO Box 11, Woden, 2601, Canberra, Australia.
Abstract:
Interferon-gamma (IFNgamma) is a pleiotropic cytokine that plays an important role in many inflammatory processes, including autoimmune diseases such as multiple sclerosis (MS). Demyelination is a hallmark of MS and a prominent pathological feature of several other inflammatory diseases of the central nervous system, including experimental autoimmune encephalomyelitis, an animal model of MS. Accordingly, in this study we followed the effect of IFNgamma in the demyelination and remyelination process by using an experimental autoimmune encephalomyelitis model of demyelination/remyelination after exposure of mice to the neurotoxic agent cuprizone. We show that demyelination in response to cuprizone is delayed in mice lacking the binding chain of IFNgamma receptor. In addition, IFNgammaR(-/-) mice exhibited an accelerated remyelination process after cuprizone was removed from the diet. Our results also indicate that the levels of IFNgamma were able to modulate the microglia/macrophage recruitment to the demyelinating areas. Moreover, the accelerated regenerative response showed by the IFNgammaR(-/-) mice was associated with a more efficient recruitment of oligodendrocyte precursor cells in the demyelinated areas. In conclusion, this study suggests that IFNgamma regulates the development and resolution of the demyelinating syndrome and may be associated with toxic effects on both mature oligodendrocytes and oligodendrocyte precursor cells.
Insights
Interferon-gamma (IFNgamma) delays demyelination and impairs remyelination in a mouse model. Blocking IFNgamma signaling accelerates central nervous system repair and oligodendrocyte precursor cell recruitment.
Area of Science:
- Neuroimmunology
- Cellular and Molecular Neuroscience
Background:
- Interferon-gamma (IFNgamma) is a key cytokine in inflammatory responses.
- Demyelination is a central pathological feature of multiple sclerosis (MS) and related CNS disorders.
Purpose of the Study:
- To investigate the role of IFNgamma in demyelination and remyelination using a mouse model.
- To elucidate how IFNgamma signaling affects oligodendrocyte precursor cells and glial responses during CNS injury.
Main Methods:
- Utilized the cuprizone-induced demyelination model in mice lacking the IFNgamma receptor (IFNgammaR(-/-)).
- Assessed demyelination and remyelination dynamics, glial cell recruitment (microglia/macrophages), and oligodendrocyte precursor cell (OPC) infiltration.
Main Results:
- IFNgammaR(-/-) mice showed delayed demyelination and accelerated remyelination following cuprizone exposure.
- IFNgamma levels modulated microglia/macrophage recruitment to demyelinating lesions.
- Enhanced remyelination in IFNgammaR(-/-) mice correlated with improved OPC recruitment.
Conclusions:
- IFNgamma signaling critically regulates the development and resolution of demyelinating syndromes.
- IFNgamma may exert toxic effects on both mature oligodendrocytes and OPCs, impacting CNS repair.
- Targeting IFNgamma pathways could offer therapeutic strategies for demyelinating diseases like MS.

